These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30138121)

  • 1. Prostate cancer multifocality, the index lesion, and the microenvironment.
    Tourinho-Barbosa RR; de la Rosette J; Sanchez-Salas R
    Curr Opin Urol; 2018 Nov; 28(6):499-505. PubMed ID: 30138121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and progress of focal therapy in Asia.
    Shiraishi T; Ukimura O
    Curr Opin Urol; 2018 Nov; 28(6):529-535. PubMed ID: 30102622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal therapy for prostate cancer: concepts and future directions.
    Ashrafi AN; Tafuri A; Cacciamani GE; Park D; de Castro Abreu AL; Gill IS
    Curr Opin Urol; 2018 Nov; 28(6):536-543. PubMed ID: 30102623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
    Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
    Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal therapy of prostate and kidney cancer.
    Aminsharifi A; de la Rosette J; Polascik TJ
    Curr Opin Urol; 2018 Nov; 28(6):491-492. PubMed ID: 30239417
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.
    Aminsharifi A; Gupta RT; Huang J; Polascik TJ
    Curr Opin Urol; 2018 Nov; 28(6):506-511. PubMed ID: 30239416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to select the right patients for focal therapy of prostate cancer?
    Passoni NM; Polascik TJ
    Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate focal therapy: the rule or exception?
    Tay KJ
    Curr Opin Urol; 2018 Nov; 28(6):512-521. PubMed ID: 30124517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
    Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
    J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
    Arcot R; Polascik TJ
    Urol Clin North Am; 2022 Feb; 49(1):129-152. PubMed ID: 34776047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
    Kamrava M; Hegde JV; Abgaryan N; Chang E; Le JD; Wang J; Kupelian PA; Marks LS
    BJU Int; 2016 Apr; 117(4):584-91. PubMed ID: 25684394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients.
    Ullrich T; Arsov C; Quentin M; Laqua N; Klingebiel M; Martin O; Hiester A; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L
    Eur J Radiol; 2019 Apr; 113():1-6. PubMed ID: 30927932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
    Dimitroulis P; Rabenalt R; Nini A; Hiester A; Esposito I; Schimmöller L; Antoch G; Albers P; Arsov C
    J Urol; 2018 Nov; 200(5):1030-1034. PubMed ID: 29733837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
    Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T
    Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
    Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
    Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
    Sidelsky S; Setia S; Vourganti S
    Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.